Mailing Address:
Harvard Medical School
Department of Population Medicine
133 Brookline Avenue, 6th Floor
Boston, MA 02215
ssoumerai@hms.harvard.edu
Phone: (617) 509-9942
Fax: (617) 859-9853
|
Stephen Soumerai, ScD
Stephen B. Soumerai is Professor of Population Medicine at Harvard Medical School and Harvard Pilgrim Health Care Institute, where he directs the Drug Policy Research Group, a research and fellowship training program focused on pharmaceutical outcomes and quality of health care which is also a World Health Organization Collaborating Center in Pharmaceutical Policy. He also co-chairs the Statistics and Evaluative Sciences concentration of the Harvard University-wide PhD program in Health Policy, and has led or been a member of numerous federal and international advisory and peer review committees for prioritizing and funding health services research. He recently served as International Trustee for the Canadian Health Services Research Foundation. Dr. Soumerai is the recipient of numerous honors including several article of the year awards from national and international scientific societies, named lectureships, and the Everett Mendelsohn Excellence in Mentoring Award from the Harvard University Graduate School of Arts and Sciences.
Dr. Soumerai has published over 200 original scientific articles in leading scientific journals, such as the New England Journal of Medicine and the Journal of the American Medical Association, and is well known nationally and internationally for his work on the impacts of health policies and methods to improve the quality of medical practice. Recently, Dr. Soumerai has led numerous federally-funded studies on cost-related underuse of medications; and the impacts of drug coverage and cost-containment policies on access to effective medications, quality and costs of care and clinical outcomes among vulnerable populations, such as chronically ill elderly and the chronically mentally ill. He frequently advises Congress, state legislatures, and federal and international agencies on the design of drug cost containment, coverage and quality-of-care policies. His research has been used extensively to support expanded economic access to medications in Medicaid and Medicare.
Dr. Soumerai received his Doctor of Science degree in Health Services Administration (Research) at the Harvard School of Public Health.
Selected Publications:
Zhang F,Wagner AK,Soumerai SB,Ross-Degnan D,.
Methods for estimating confidence intervals in interrupted time series analyses of health interventions
.
J Clin Epidemiol. 2009 Feb;2:143-148
Tjia J,Briesacher BA,Soumerai SB,Pierre-Jacques M,Zhang F,Ross-Degnan D,Gurwitz JH,.
Medicare beneficiaries and free prescription drug samples: a national survey
.
J Gen Intern Med. 2008 Jun;6:709-714
Morden NE,Zerzan JT,Rue TC,Heagerty PJ,Roughead EE,Soumerai SB,Ross-Degnan D,Sullivan SD,.
Medicaid prior authorization and controlled-release oxycodone
.
Med Care. 2008 Jun;6:573-580
Adams AS,Trinacty CM,Zhang F,Kleinman K,Grant RW,Meigs JB,Soumerai SB,Ross-Degnan D,.
Medication adherence and racial differences in A1C control
.
Diabetes Care. 2008 May;5:916-921
Soumerai SB,Zhang F,Ross-Degnan D,Ball DE,LeCates RF,Law MR,Hughes TE,Chapman D,Adams AS,.
Use of atypical antipsychotic drugs for schizophrenia in Maine Medicaid following a policy change
.
Health Aff (Millwood ). 2008 May;3:w185-w195
Law MR,Ross-Degnan D,Soumerai SB,.
Effect of prior authorization of second-generation antipsychotic agents on pharmacy utilization and reimbursements
.
Psychiatr Serv. 2008 May;5:540-546
Wharam JF,Galbraith AA,Kleinman KP,Soumerai SB,Ross-Degnan D,Landon BE,.
Cancer screening before and after switching to a high-deductible health plan
.
Ann Intern Med. 2008 May 6;9:647-655
Madden JM,Graves AJ,Zhang F,Adams AS,Briesacher BA,Ross-Degnan D,Gurwitz JH,Pierre-Jacques M,Safran DG,Adler GS,Soumerai SB,.
Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D
.
JAMA. 2008 Apr 23;16:1922-1928
Pierre-Jacques M,Safran DG,Zhang F,Ross-Degnan D,Adams AS,Gurwitz J,Rusinak D,Soumerai SB,.
Reliability of new measures of cost-related medication nonadherence
.
Med Care. 2008 Apr;4:444-448
Smith DH,Kramer JM,Perrin N,Platt R,Roblin DW,Lane K,Goodman M,Nelson WW,Yang X,Soumerai SB,.
A randomized trial of direct-to-patient communication to enhance adherence to beta-blocker therapy following myocardial infarction
.
Arch Intern Med. 2008 Mar 10;5:477-483
Finkelstein JA,Huang SS,Kleinman K,Rifas-Shiman SL,Stille CJ,Daniel J,Schiff N,Steingard R,Soumerai SB,Ross-Degnan D,Goldmann D,Platt R,.
Impact of a 16-community trial to promote judicious antibiotic use in Massachusetts
.
Pediatrics. 2008 Jan;1:e15-e23
Law MR,Soumerai SB,Ross-Degnan D,Adams AS,.
A longitudinal study of medication nonadherence and hospitalization risk in schizophrenia
.
J Clin Psychiatry. 2008 Jan;1:47-53
Lu CY,Ross-Degnan D,Soumerai SB,Pearson SA,.
Interventions designed to improve the quality and efficiency of medication use in managed care: a critical review of the literature - 2001-2007
.
BMC Health Serv Res. 2008;75-
Law MR,Majumdar SR,Soumerai SB,.
Effect of illicit direct to consumer advertising on use of etanercept, mometasone, and tegaserod in Canada: controlled longitudinal study
.
BMJ. 2008;a1055-
|
